Samit Hirawat, Bristol Myers Squibb EVP, CMO, Global Drug Development

Bris­tol My­ers jumps in­to the M&A game with a $4B on­col­o­gy buy­out. And weary biotech an­a­lysts could­n't be any hap­pi­er

Bris­tol My­ers Squibb has nabbed Turn­ing Point Ther­a­peu­tics in a $4.1 bil­lion buy­out deal, just weeks af­ter the biotech post­ed an up­beat round of pos­i­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.